Thanks to the NIH, researchers like Andrew Ewald have advanced our understanding of what allows a cancer cell from one part ...

A novel DIPN method enhances GA segmentation by integrating ConvLSTM, projection attention, adaptive pooling, and contrastive ...

NASDAQ:FBLG Hello and welcome to Virtual Investor Conferences. On behalf of the Life Sciences Investor Forum and our co-host, Zacks Small Cap Research, we're very pleased you joined us for our ...

More than 90% of cancer deaths in America are attributable to metastasis, when cancer spreads from its original site to other ...

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that the ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

QC Kinetix, a leader in regenerative medicine, is enhancing non-surgical pain relief by implementing 10 billion platelet dosing for PRP treatments.

The global antibody market is poised for remarkable expansion over the next decade, with market estimates predicting a significant rise in valuation from USD 266.83 billion in 2024 to an impressive ...

Can be recycled via drop-off programmes with standard EPS or can biodegrade over 90% within four years in a landfill.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

From my colleague Allison DeAngelis: Over the last few years, the drug industry has rushed to retool CAR-T treatments for ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...